Bristol Myers Squibb said it will expand its partnership with NVIDIA to build what it describes as the most powerful and energy-efficient wholly owned AI infrastructure in the life-sciences industry, aiming to accelerate the discovery and development of new medicines.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.